Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-01-19

AUTHORS

Pierre Bouju, Jean-Marc Tadié, Nicolas Barbarot, Julien Letheulle, Fabrice Uhel, Pierre Fillatre, Guillaume Grillet, Angélique Goepp, Yves Le Tulzo, Arnaud Gacouin

ABSTRACT

BACKGROUND: Despite few studies, a monitoring of a neuromuscular blockade with a train of four (TOF) is recommended in intensive care unit (ICU). Our objective was to compare the results of ulnar and facial TOF measurements with an overall clinical assessment for neuromuscular blockade in ICU patients treated with recommended doses of atracurium or cisatracurium, including patients with acute respiratory disease syndrome (ARDS). METHODS: We prospectively included in two ICUs 119 patients, 94 with ARDS, who required a neuromuscular blockade for more than 24 h. Three levels of neuromuscular blockade were defined: "over-paralyzed" (TOF = 0), "well-paralyzed" (TOF = 1-2), and "under-paralyzed" (TOF = 3-4). Physicians blinded for TOF counts were asked to classify patients clinically as "over-paralyzed," "well-paralyzed," or "under-paralyzed". Patients were assessed two times daily. RESULTS: For the whole population 996 ulnar and facial TOF measurements and clinical assessments were obtained (846 with cisatracurium and 150 with atracurium). Proportions of patients classified as over-paralyzed, well-paralyzed, and under-paralyzed based on TOF measurements and clinical assessments differed significantly (p < 0.0001). The number of observed agreements between clinical assessments and facial TOF measurements was of 19.08% (κ = 0.06) and of 17.37% with ulnar TOF measurements (κ = 0.04), while it was of 62.75% between ulnar and facial TOF measurements (κ = 0.45). Results were similar for cisatracurium and atracurium. Repeated facial TOF measurements performed on the first 4 days of mechanical ventilation in ARDS patients showed that the proportion of patients TOF = 1-2 was around 8% and did not vary significantly with time (p = 0.9), proportion of patients TOF = 3-4 increased from 24 to 40% (p = 0.01), proportion of patients TOF = 0 decreased from 71 to 53% (p = 0.005) while objectives for protective ventilation were achieved. Proportions of facial and ulnar TOF = 0 were significantly higher among patients with ICU-acquired weakness (ICU-AW) versus those who did not develop ICU-AW (51 vs. 40%, p = 0.03, and 76 vs. 62%, p = 0.006, respectively). CONCLUSIONS: The study provides data on clinical and TOF monitoring of neuromuscular blockade, which are widely divergent in ICU patients receiving recommended doses of benzylisoquinoliniums. More... »

PAGES

10

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0

DOI

http://dx.doi.org/10.1186/s13613-017-0234-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008943407

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28102521


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462699.6", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bouju", 
        "givenName": "Pierre", 
        "id": "sg:person.01207334156.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207334156.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.410368.8", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France", 
            "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tadi\u00e9", 
        "givenName": "Jean-Marc", 
        "id": "sg:person.0765631760.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765631760.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "R\u00e9animation polyvalente, CH Saint-Brieuc, 22000 Saint-Brieuc, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "R\u00e9animation polyvalente, CH Saint-Brieuc, 22000 Saint-Brieuc, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barbarot", 
        "givenName": "Nicolas", 
        "id": "sg:person.01272000323.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272000323.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462699.6", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Letheulle", 
        "givenName": "Julien", 
        "id": "sg:person.0736551220.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736551220.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.410368.8", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France", 
            "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Uhel", 
        "givenName": "Fabrice", 
        "id": "sg:person.01033600764.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033600764.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.462699.6", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fillatre", 
        "givenName": "Pierre", 
        "id": "sg:person.01273730565.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273730565.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.411154.4", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grillet", 
        "givenName": "Guillaume", 
        "id": "sg:person.01171303723.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171303723.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "R\u00e9animation polyvalente, CH Saint-Brieuc, 22000 Saint-Brieuc, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "R\u00e9animation polyvalente, CH Saint-Brieuc, 22000 Saint-Brieuc, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goepp", 
        "givenName": "Ang\u00e9lique", 
        "id": "sg:person.012564331073.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012564331073.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.410368.8", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France", 
            "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Le Tulzo", 
        "givenName": "Yves", 
        "id": "sg:person.01272505323.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272505323.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033 Rennes, France", 
          "id": "http://www.grid.ac/institutes/grid.410368.8", 
          "name": [
            "Service des Maladies Infectieuses et R\u00e9animation M\u00e9dicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France", 
            "Facult\u00e9 de M\u00e9decine, Biosit, Universit\u00e9 Rennes 1, 35043 Rennes, France", 
            "Inserm-CIC-1414, Universit\u00e9 Rennes I, IFRI 40, 35033 Rennes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gacouin", 
        "givenName": "Arnaud", 
        "id": "sg:person.0725601723.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725601723.28"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00134-002-1508-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046818553", 
          "https://doi.org/10.1007/s00134-002-1508-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01709751", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052044737", 
          "https://doi.org/10.1007/bf01709751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001340100964", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036337037", 
          "https://doi.org/10.1007/s001340100964"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2110-5820-4-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031728464", 
          "https://doi.org/10.1186/2110-5820-4-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc12557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008813810", 
          "https://doi.org/10.1186/cc12557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40140-016-0155-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019235061", 
          "https://doi.org/10.1007/s40140-016-0155-8"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-01-19", 
    "datePublishedReg": "2017-01-19", 
    "description": "BACKGROUND: Despite few studies, a monitoring of a neuromuscular blockade with a train of four (TOF) is recommended in intensive care unit (ICU). Our objective was to compare the results of ulnar and facial TOF measurements with an overall clinical assessment for neuromuscular blockade in ICU patients treated with recommended doses of atracurium or cisatracurium, including patients with acute respiratory disease syndrome (ARDS).\nMETHODS: We prospectively included in two ICUs 119 patients, 94 with ARDS, who required a neuromuscular blockade for more than 24\u00a0h. Three levels of neuromuscular blockade were defined: \"over-paralyzed\" (TOF\u00a0=\u00a00), \"well-paralyzed\" (TOF\u00a0=\u00a01-2), and \"under-paralyzed\" (TOF\u00a0=\u00a03-4). Physicians blinded for TOF counts were asked to classify patients clinically as \"over-paralyzed,\" \"well-paralyzed,\" or \"under-paralyzed\". Patients were assessed two times daily.\nRESULTS: For the whole population 996 ulnar and facial TOF measurements and clinical assessments were obtained (846 with cisatracurium and 150 with atracurium). Proportions of patients classified as over-paralyzed, well-paralyzed, and under-paralyzed based on TOF measurements and clinical assessments differed significantly (p\u00a0<\u00a00.0001). The number of observed agreements between clinical assessments and facial TOF measurements was of 19.08% (\u03ba\u00a0=\u00a00.06) and of 17.37% with ulnar TOF measurements (\u03ba\u00a0=\u00a00.04), while it was of 62.75% between ulnar and facial TOF measurements (\u03ba\u00a0=\u00a00.45). Results were similar for cisatracurium and atracurium. Repeated facial TOF measurements performed on the first 4\u00a0days of mechanical ventilation in ARDS patients showed that the proportion of patients TOF\u00a0=\u00a01-2 was around 8% and did not vary significantly with time (p\u00a0=\u00a00.9), proportion of patients TOF\u00a0=\u00a03-4 increased from 24 to 40% (p\u00a0=\u00a00.01), proportion of patients TOF\u00a0=\u00a00 decreased from 71 to 53% (p\u00a0=\u00a00.005) while objectives for protective ventilation were achieved. Proportions of facial and ulnar TOF\u00a0=\u00a00 were significantly higher among patients with ICU-acquired weakness (ICU-AW) versus those who did not develop ICU-AW (51 vs. 40%, p\u00a0=\u00a00.03, and 76 vs. 62%, p\u00a0=\u00a00.006, respectively).\nCONCLUSIONS: The study provides data on clinical and TOF monitoring of neuromuscular blockade, which are widely divergent in ICU patients receiving recommended doses of benzylisoquinoliniums.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13613-017-0234-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1045300", 
        "issn": [
          "2110-5820"
        ], 
        "name": "Annals of Intensive Care", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "keywords": [
      "acute respiratory disease syndrome", 
      "intensive care unit", 
      "neuromuscular blockade", 
      "clinical assessment", 
      "ICU patients", 
      "doses of atracurium", 
      "doses of cisatracurium", 
      "proportion of patients", 
      "prospective descriptive study", 
      "overall clinical assessment", 
      "respiratory disease syndrome", 
      "protective ventilation", 
      "ARDS patients", 
      "ICU-AW", 
      "ill patients", 
      "care unit", 
      "mechanical ventilation", 
      "TOF count", 
      "TOF monitoring", 
      "patients", 
      "blockade", 
      "cisatracurium", 
      "atracurium", 
      "descriptive study", 
      "disease syndrome", 
      "doses", 
      "ventilation", 
      "observed agreement", 
      "proportion", 
      "assessment", 
      "syndrome", 
      "benzylisoquinoliniums", 
      "physicians", 
      "study", 
      "count", 
      "days", 
      "TOF", 
      "objective", 
      "monitoring", 
      "levels", 
      "weakness", 
      "time", 
      "results", 
      "measurements", 
      "data", 
      "number", 
      "units", 
      "train", 
      "agreement", 
      "TOF measurements", 
      "facial TOF measurements", 
      "ICUs 119 patients", 
      "whole population 996", 
      "population 996", 
      "ulnar TOF measurements", 
      "patients TOF", 
      "ulnar TOF", 
      "doses of benzylisoquinoliniums"
    ], 
    "name": "Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study", 
    "pagination": "10", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008943407"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13613-017-0234-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28102521"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13613-017-0234-0", 
      "https://app.dimensions.ai/details/publication/pub.1008943407"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_729.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13613-017-0234-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13613-017-0234-0'


 

This table displays all metadata directly associated to this object as RDF triples.

218 TRIPLES      22 PREDICATES      90 URIs      76 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13613-017-0234-0 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N4bb71fc3f0604546a67a54974263629d
4 schema:citation sg:pub.10.1007/bf01709751
5 sg:pub.10.1007/s00134-002-1508-y
6 sg:pub.10.1007/s001340100964
7 sg:pub.10.1007/s40140-016-0155-8
8 sg:pub.10.1186/2110-5820-4-3
9 sg:pub.10.1186/cc12557
10 schema:datePublished 2017-01-19
11 schema:datePublishedReg 2017-01-19
12 schema:description BACKGROUND: Despite few studies, a monitoring of a neuromuscular blockade with a train of four (TOF) is recommended in intensive care unit (ICU). Our objective was to compare the results of ulnar and facial TOF measurements with an overall clinical assessment for neuromuscular blockade in ICU patients treated with recommended doses of atracurium or cisatracurium, including patients with acute respiratory disease syndrome (ARDS). METHODS: We prospectively included in two ICUs 119 patients, 94 with ARDS, who required a neuromuscular blockade for more than 24 h. Three levels of neuromuscular blockade were defined: "over-paralyzed" (TOF = 0), "well-paralyzed" (TOF = 1-2), and "under-paralyzed" (TOF = 3-4). Physicians blinded for TOF counts were asked to classify patients clinically as "over-paralyzed," "well-paralyzed," or "under-paralyzed". Patients were assessed two times daily. RESULTS: For the whole population 996 ulnar and facial TOF measurements and clinical assessments were obtained (846 with cisatracurium and 150 with atracurium). Proportions of patients classified as over-paralyzed, well-paralyzed, and under-paralyzed based on TOF measurements and clinical assessments differed significantly (p < 0.0001). The number of observed agreements between clinical assessments and facial TOF measurements was of 19.08% (κ = 0.06) and of 17.37% with ulnar TOF measurements (κ = 0.04), while it was of 62.75% between ulnar and facial TOF measurements (κ = 0.45). Results were similar for cisatracurium and atracurium. Repeated facial TOF measurements performed on the first 4 days of mechanical ventilation in ARDS patients showed that the proportion of patients TOF = 1-2 was around 8% and did not vary significantly with time (p = 0.9), proportion of patients TOF = 3-4 increased from 24 to 40% (p = 0.01), proportion of patients TOF = 0 decreased from 71 to 53% (p = 0.005) while objectives for protective ventilation were achieved. Proportions of facial and ulnar TOF = 0 were significantly higher among patients with ICU-acquired weakness (ICU-AW) versus those who did not develop ICU-AW (51 vs. 40%, p = 0.03, and 76 vs. 62%, p = 0.006, respectively). CONCLUSIONS: The study provides data on clinical and TOF monitoring of neuromuscular blockade, which are widely divergent in ICU patients receiving recommended doses of benzylisoquinoliniums.
13 schema:genre article
14 schema:inLanguage en
15 schema:isAccessibleForFree true
16 schema:isPartOf N5e0df04194224e279c356a5c6457a272
17 Na779694e4a6249b7912837db255395b1
18 sg:journal.1045300
19 schema:keywords ARDS patients
20 ICU patients
21 ICU-AW
22 ICUs 119 patients
23 TOF
24 TOF count
25 TOF measurements
26 TOF monitoring
27 acute respiratory disease syndrome
28 agreement
29 assessment
30 atracurium
31 benzylisoquinoliniums
32 blockade
33 care unit
34 cisatracurium
35 clinical assessment
36 count
37 data
38 days
39 descriptive study
40 disease syndrome
41 doses
42 doses of atracurium
43 doses of benzylisoquinoliniums
44 doses of cisatracurium
45 facial TOF measurements
46 ill patients
47 intensive care unit
48 levels
49 measurements
50 mechanical ventilation
51 monitoring
52 neuromuscular blockade
53 number
54 objective
55 observed agreement
56 overall clinical assessment
57 patients
58 patients TOF
59 physicians
60 population 996
61 proportion
62 proportion of patients
63 prospective descriptive study
64 protective ventilation
65 respiratory disease syndrome
66 results
67 study
68 syndrome
69 time
70 train
71 ulnar TOF
72 ulnar TOF measurements
73 units
74 ventilation
75 weakness
76 whole population 996
77 schema:name Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study
78 schema:pagination 10
79 schema:productId N03919a1dcb0445a8b71abf6c4947a3cc
80 Nfaf22a40a90e4ed3bf50fc792b734177
81 Nfb55773f029c4b9a87eabda26b9eaa5f
82 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008943407
83 https://doi.org/10.1186/s13613-017-0234-0
84 schema:sdDatePublished 2022-01-01T18:43
85 schema:sdLicense https://scigraph.springernature.com/explorer/license/
86 schema:sdPublisher N1a5dcbb383a54e50810168ec47fb58ea
87 schema:url https://doi.org/10.1186/s13613-017-0234-0
88 sgo:license sg:explorer/license/
89 sgo:sdDataset articles
90 rdf:type schema:ScholarlyArticle
91 N03919a1dcb0445a8b71abf6c4947a3cc schema:name dimensions_id
92 schema:value pub.1008943407
93 rdf:type schema:PropertyValue
94 N1a5dcbb383a54e50810168ec47fb58ea schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 N1b538b5228c04656ae4b88aff3535731 rdf:first sg:person.012564331073.04
97 rdf:rest Nd1149e7d532d41ff82abd793f69e87b9
98 N35c76f98dc4d449f9838989b4ce198fd rdf:first sg:person.0736551220.58
99 rdf:rest N6bb86c930ad744c0b33be61c51c63e48
100 N3b28aaabf9eb44c7afb0298e6ed70d8f rdf:first sg:person.01273730565.40
101 rdf:rest N7c9eb5a933ee4646a1d74573966caa18
102 N4bb71fc3f0604546a67a54974263629d rdf:first sg:person.01207334156.95
103 rdf:rest Nc6ad1bdf4aa44cc0bc6223b0ea67e23b
104 N5e0df04194224e279c356a5c6457a272 schema:issueNumber 1
105 rdf:type schema:PublicationIssue
106 N6bb86c930ad744c0b33be61c51c63e48 rdf:first sg:person.01033600764.36
107 rdf:rest N3b28aaabf9eb44c7afb0298e6ed70d8f
108 N78dd362d019c4778add1275fdb98a86a rdf:first sg:person.01272000323.25
109 rdf:rest N35c76f98dc4d449f9838989b4ce198fd
110 N7c9eb5a933ee4646a1d74573966caa18 rdf:first sg:person.01171303723.73
111 rdf:rest N1b538b5228c04656ae4b88aff3535731
112 N807bb49757d04e149b8a0aec51e1a5c1 rdf:first sg:person.0725601723.28
113 rdf:rest rdf:nil
114 Na779694e4a6249b7912837db255395b1 schema:volumeNumber 7
115 rdf:type schema:PublicationVolume
116 Nc6ad1bdf4aa44cc0bc6223b0ea67e23b rdf:first sg:person.0765631760.11
117 rdf:rest N78dd362d019c4778add1275fdb98a86a
118 Nd1149e7d532d41ff82abd793f69e87b9 rdf:first sg:person.01272505323.78
119 rdf:rest N807bb49757d04e149b8a0aec51e1a5c1
120 Nfaf22a40a90e4ed3bf50fc792b734177 schema:name doi
121 schema:value 10.1186/s13613-017-0234-0
122 rdf:type schema:PropertyValue
123 Nfb55773f029c4b9a87eabda26b9eaa5f schema:name pubmed_id
124 schema:value 28102521
125 rdf:type schema:PropertyValue
126 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
127 schema:name Medical and Health Sciences
128 rdf:type schema:DefinedTerm
129 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
130 schema:name Clinical Sciences
131 rdf:type schema:DefinedTerm
132 sg:journal.1045300 schema:issn 2110-5820
133 schema:name Annals of Intensive Care
134 schema:publisher Springer Nature
135 rdf:type schema:Periodical
136 sg:person.01033600764.36 schema:affiliation grid-institutes:grid.410368.8
137 schema:familyName Uhel
138 schema:givenName Fabrice
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033600764.36
140 rdf:type schema:Person
141 sg:person.01171303723.73 schema:affiliation grid-institutes:grid.411154.4
142 schema:familyName Grillet
143 schema:givenName Guillaume
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171303723.73
145 rdf:type schema:Person
146 sg:person.01207334156.95 schema:affiliation grid-institutes:grid.462699.6
147 schema:familyName Bouju
148 schema:givenName Pierre
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207334156.95
150 rdf:type schema:Person
151 sg:person.012564331073.04 schema:affiliation grid-institutes:None
152 schema:familyName Goepp
153 schema:givenName Angélique
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012564331073.04
155 rdf:type schema:Person
156 sg:person.01272000323.25 schema:affiliation grid-institutes:None
157 schema:familyName Barbarot
158 schema:givenName Nicolas
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272000323.25
160 rdf:type schema:Person
161 sg:person.01272505323.78 schema:affiliation grid-institutes:grid.410368.8
162 schema:familyName Le Tulzo
163 schema:givenName Yves
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272505323.78
165 rdf:type schema:Person
166 sg:person.01273730565.40 schema:affiliation grid-institutes:grid.462699.6
167 schema:familyName Fillatre
168 schema:givenName Pierre
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01273730565.40
170 rdf:type schema:Person
171 sg:person.0725601723.28 schema:affiliation grid-institutes:grid.410368.8
172 schema:familyName Gacouin
173 schema:givenName Arnaud
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725601723.28
175 rdf:type schema:Person
176 sg:person.0736551220.58 schema:affiliation grid-institutes:grid.462699.6
177 schema:familyName Letheulle
178 schema:givenName Julien
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736551220.58
180 rdf:type schema:Person
181 sg:person.0765631760.11 schema:affiliation grid-institutes:grid.410368.8
182 schema:familyName Tadié
183 schema:givenName Jean-Marc
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765631760.11
185 rdf:type schema:Person
186 sg:pub.10.1007/bf01709751 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052044737
187 https://doi.org/10.1007/bf01709751
188 rdf:type schema:CreativeWork
189 sg:pub.10.1007/s00134-002-1508-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1046818553
190 https://doi.org/10.1007/s00134-002-1508-y
191 rdf:type schema:CreativeWork
192 sg:pub.10.1007/s001340100964 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036337037
193 https://doi.org/10.1007/s001340100964
194 rdf:type schema:CreativeWork
195 sg:pub.10.1007/s40140-016-0155-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019235061
196 https://doi.org/10.1007/s40140-016-0155-8
197 rdf:type schema:CreativeWork
198 sg:pub.10.1186/2110-5820-4-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031728464
199 https://doi.org/10.1186/2110-5820-4-3
200 rdf:type schema:CreativeWork
201 sg:pub.10.1186/cc12557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008813810
202 https://doi.org/10.1186/cc12557
203 rdf:type schema:CreativeWork
204 grid-institutes:None schema:alternateName Réanimation polyvalente, CH Saint-Brieuc, 22000 Saint-Brieuc, France
205 schema:name Réanimation polyvalente, CH Saint-Brieuc, 22000 Saint-Brieuc, France
206 rdf:type schema:Organization
207 grid-institutes:grid.410368.8 schema:alternateName Inserm-CIC-1414, Université Rennes I, IFRI 40, 35033 Rennes, France
208 schema:name Faculté de Médecine, Biosit, Université Rennes 1, 35043 Rennes, France
209 Inserm-CIC-1414, Université Rennes I, IFRI 40, 35033 Rennes, France
210 Service des Maladies Infectieuses et Réanimation Médicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France
211 rdf:type schema:Organization
212 grid-institutes:grid.411154.4 schema:alternateName Service des Maladies Infectieuses et Réanimation Médicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France
213 schema:name Service des Maladies Infectieuses et Réanimation Médicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France
214 rdf:type schema:Organization
215 grid-institutes:grid.462699.6 schema:alternateName Faculté de Médecine, Biosit, Université Rennes 1, 35043 Rennes, France
216 schema:name Faculté de Médecine, Biosit, Université Rennes 1, 35043 Rennes, France
217 Service des Maladies Infectieuses et Réanimation Médicale, CHU Rennes, 2 rue Henri Le Guilloux, 35033 Rennes, France
218 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...